RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SPERDUTI I
Collezione AOU San Luigi di Orbassano

Items : 10

Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma. in Clinical lung cancer / Clin Lung Cancer. 2025 Jan 9:S1525-7304(25)00002-6. doi: 10.1016/j.cllc.2025.01.001.

2025
AOU San Luigi di Orbassano

Tajè R; Ambrogi V; Tacconi F; Gallina FT; Alessandrini G; Forcella D; Buglioni S; Visca P; Patirelis A; Cecere FL; Melis E; Vidiri A; Sperduti I; Cappuzzo F; Novello S; Caterino M; Facciolo F;

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.

2022
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Brunelli M; Battelli N; Buttigliero C; Caserta C; Buti S; Santini D; Carella C; Galli L; Verri E; Ermacora P; Merler S; Masini C; De Vivo R; Milesi L; Spina F; Rizzo M; Sperduti I; Fornarini G; Tortora G;

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.

2022
AOU San Luigi di Orbassano

Pilotto S; Avancini A; Menis J; Sperduti I; Giaj Levra M; Berghmans T; Bironzo P; Brandão M; De Ruysscher D; Edwards J; Faivre-Finn C; Girard N; Greillier L; Hendriks L; Lantuejoul S; Mauer M; Novello S; O'Brien M; Reck M; Reguart N; Remon J; von der Thüsen J; Dingemans AC; Besse B; Milella M;

Which Is the Best Treatment in Recurrent Thymoma? A Systematic Review and Meta-Analysis. in Cancers / Cancers (Basel). 2021 Mar 29;13(7):1559. doi: 10.3390/cancers13071559.

2021
AOU San Luigi di Orbassano

Chiappetta M; Grossi U; Sperduti I; Margaritora S; Marulli G; Fiorelli A; Sandri A; Mizuno T; Cusumano G; Hamaji M; Cesario A; Lococo F;

Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2020 Feb;18(1):69-76.e4. doi: 10.1016/j.clgc.2019.09.010. Epub 2019 Sep 27.

2020
AOU San Luigi di Orbassano

Pappagallo G; Galli L; Gelderblom H; Tucci M; De Giorgi U; Zagonel V; Sella A; Bournakis E; Yu EY; Schmid S; Thomsen FB; Bergman A; Bianchini D; Wissing M; Caffo O; Bria E; Sperduti I; Oudard S;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperduti I; Aglietta M; Cagnazzo C; Di Stefano TS; Di Costanzo A; Matocci R; Chiari R; Petrillo P; Galetta D; Arizio F; Di Maio M; Polo V; Pasello G; Pilotto S; Gobbini E; Bria E; Novello S; Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; et alii...

Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Apr;13(4):568-575. doi: 10.1016/j.jtho.2017.12.003. Epub 2017 Dec 18.

2018
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; Scarpa A; Infante M; Tortora G; Facciolo F; Bria E; Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; et alii...

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.

2015
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma. in Oncotarget / Oncotarget. 2015 May 20;6(14):12783-95. doi: 10.18632/oncotarget.3727.

2015
AOU San Luigi di Orbassano

Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.

2015
AOU San Luigi di Orbassano

Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A;